Compare
HeartSciences Inc. vs NetBrands Corp. vs T-REX Acquisition Corp. vs Sentage Holdings Inc.
| Latest fiscal year | HeartSciences Inc. HSCS | NetBrands Corp. NBND | T-REX Acquisition Corp. TRXA | Sentage Holdings Inc. SNTG |
|---|---|---|---|---|
| Year ended | 2026-04-30 | 2025-12-31 | 2025-06-30 | 2025-12-31 |
| Revenue | $4.3K | $18.3K | $32.4K | $68.9K |
| Revenue growth (YoY) | -0.7% | n/a | +104.7% | -35.9% |
| Gross margin | 59.1% | 52.0% | -266.1% | 91.2% |
| Operating margin | n/m | n/m | n/m | n/m |
| Net margin | n/m | n/m | n/m | n/m |
| Net income | -$9.14M | -$1.70M | -$2.54M | -$2.28M |
| EPS (Diluted) | n/a | -$0.02 | -$0.13 | -$0.81 |
| Operating cash flow | -$7.43M | -$336.9K | -$763.8K | -$1.31M |
| Free cash flow | -$7.43M | n/a | n/a | n/a |
| Cash & equivalents | $1.70M | $4.3K | n/a | $477.6K |
| Total assets | n/a | $102.2K | $774.3K | $9.88M |
| Total liabilities | n/a | $2.52M | $1.84M | $2.00M |
| Shareholders' equity | $226.1K | -$2.41M | -$1.06M | $7.88M |
| Return on year-end equity | n/m | n/a | n/a | -28.9% |
| Shares outstanding | n/a | 131.27M | 25.07M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | HeartSciences Inc. | NetBrands Corp. | T-REX Acquisition Corp. | Sentage Holdings Inc. |
|---|---|---|---|---|
| Latest | $4.3K Ended 2026-04-30 | $18.3K Ended 2025-12-31 | $32.4K Ended 2025-06-30 | $68.9K Ended 2025-12-31 |
| 1 year earlier | $4.3K Ended 2025-04-30 | n/a | $15.8K Ended 2024-06-30 | $107.5K Ended 2024-12-31 |
| 2 years earlier | $18.6K Ended 2024-04-30 | $644.5K Ended 2023-12-31 | $55.6K Ended 2023-06-30 | $146.6K Ended 2023-12-31 |
| 3 years earlier | $5.2K Ended 2023-04-30 | $1.64M Ended 2022-12-31 | $44.1K Ended 2022-06-30 | $161.4K Ended 2022-12-31 |
| 4 years earlier | $14.4K Ended 2022-04-30 | $2.67M Ended 2021-12-31 | $0 Ended 2021-06-30 | $2.26M Ended 2021-12-31 |